Financial service company, UBS, projects a higher Price Target (PT) for Oracle (ORCL), adjusting it to $280 while maintaining a ‘buy’ rating. Earning calls indicate accelerating revenue growth resulting from rising CapEx, backed by Cloud Surge and strategic investments. Part of ORCL's strategy, their AI-led growth prospect, is boosting dividend appeal. JM Cramer likens ORCL to Palantir while focusing on citizen's rights through Oracle Fusion Cloud Advanced Inventory Management. Oracle is also contributing to the digitization of Irish Maternity Care, managing half the nation's births. Warning signals from analysts point towards a potential need for ORCL to raise more capital. However, the investor's interest in the stock remains high as ORCL's share price maintains a firm position. Furthermore, a potentially significant move by Oracle announced in a deal to purchase $40 Billion Nvidia Chips for its OpenAI Data Center Project. Endorsement by Polen Focus Growth Strategy and a speculated 4.5?GW deal with OpenAI has Oracle's innovation appeal soaring.
Oracle Corp ORCL News Analytics from Mon, 02 Dec 2024 08:00:00 GMT to Fri, 01 Aug 2025 23:26:25 GMT - Rating 7 - Innovation 8 - Information 6 - Rumor 5
